Ascendis Pharma A/S vs Chipotle Mexican Grill, Inc. — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Chipotle Mexican Grill, Inc. trades at $32.66 (market cap $40.49B). The key difference: Chipotle Mexican Grill, Inc. is far larger — about 2.4× Ascendis Pharma A/S's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Chipotle Mexican Grill, Inc. nearer its low. Which is the better fit depends on your goals.
| ASND | CMG | |
|---|---|---|
Market Cap | $16.67B | $40.49B |
Sector | Health | Consumer Cyclical |
52-Week High | $277.18 | $44.04 |
52-Week Low | $189.74 | $28.17 |
Enterprise Value | $17.04B | $45.24B |
Trailing returns across standard periods
Latest headlines on both assets
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Read more on CMG →